Largest Sale to Date for GT Solar

GT Solar Incorporated, a key global provider of a comprehensive range of equipment and turnkey manufacturing solutions to the solar power industry, announced today it has signed a follow-on contract valued at approximately $200 million to supply DC Chemical Co., Ltd. (DCC) of South Korea with polysilicon reactors. The equipment will be used by DCC to expand their facility in Gunsan, South Korea. This represents the largest single order received by GT Solar to date.

The contract is for GT’s chemical vapor deposition polysilicon reactor. GT’s latest technology reactor incorporates design improvements that increase reliability and boost polysilicon production by more than 30% over the previous design.

GT Solar CEO, Thomas Zarrella, noted, “This contract is a major validation of our innovation and insight into the evolving needs of the solar power industry. By helping to alleviate what has been a global shortage of polysilicon over the past several years, GT Solar has helped foster greater industry growth while diversifying its own product mix.”

GT’s VP for Polysilicon, David Keck, said: “DCC is one of the largest new entrants into the polysilicon market and is an important client to our team here at GT Solar. We are delighted to be able to continue to meet the demands of an important repeat customer like DCC. We look forward to continuing this collaboration in the future.”

DCC Vice Chairman, Mr. Shin, noted, “As a customer of GT Solar, we have come to value GT and look forward to continuing our relationship as we work to meet the ever growing needs of the solar power industry.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.